Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (GU5) — Free Cash Flow Generation Index
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (GU5) has a Free Cash Flow Generation Index of 0.75x as of June 2023. Free cash flow of €1.57 Billion represents 1% of operating cash flow (€2.10 Billion). Explore Guangzhou Baiyunshan Pharmaceutical Hold capital spending ratio to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Free Cash Flow Generation Index (2013–2024)
Historical FCF Generation Index trend for Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited across 12 annual periods. For the full cash flow conversion analysis, see GU5 cash flow metrics.
Annual Free Cash Flow Generation for Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (2013–2024)
Year-by-year Free Cash Flow Generation Index for Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited. Check GU5 cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (EUR) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.67x | €2.31 Billion | €3.44 Billion | €1.13 Billion | ▲ +11.5% |
| 2023 | 0.60x | €2.48 Billion | €4.10 Billion | €1.63 Billion | ▼ -24.8% |
| 2022 | 0.80x | €5.62 Billion | €7.00 Billion | €1.38 Billion | ▲ +3.0% |
| 2021 | 0.78x | €4.42 Billion | €5.67 Billion | €1.25 Billion | ▲ +256.4% |
| 2020 | -0.50x | €-291.32 Million | €585.19 Million | €876.50 Million | ▼ -195.3% |
| 2019 | 0.52x | €2.62 Billion | €5.02 Billion | €2.40 Billion | ▼ -42.5% |
| 2018 | 0.91x | €4.74 Billion | €5.22 Billion | €478.62 Million | ▲ +1.7% |
| 2017 | 0.89x | €1.64 Billion | €1.83 Billion | €196.77 Million | ▼ -18.1% |
| 2016 | 1.09x | €2.77 Billion | €2.54 Billion | €228.03 Million | ▼ -13.9% |
| 2015 | 1.27x | €2.46 Billion | €1.94 Billion | €515.34 Million | ▲ +5.1% |
| 2014 | 1.20x | €2.11 Billion | €1.75 Billion | €356.70 Million | ▼ -4.6% |
| 2013 | 1.26x | €1.69 Billion | €1.34 Billion | €350.35 Million | — |